NeuroGeneration is a biotherapeutics company that develops new treatments and products for patients with neurological diseases, including Parkinson's Disease, Alzheimer's Disease, Epilepsy, Spinal Cord injury, Stroke and MS/ALS.
February 16, 2009
Grounbreaking paper publishes long term results of a successful Phase I Clinical Trial .. more>
October 15, 2008
NeuroGeneration named as one of 27 industry trendsetters for 2009 in Stem Cell Approaches in Neurology and Psychiatry Today ... more>
October 12-14, 2008
The Biotech Meeting.Oct 12-14, 2008. Laguna Beach, CA. Chairman-CEO Dr. Michel Levesque invited... more>
NeuroGeneration has been authorized by the FDA to conduct a phase II clinical trial for Parkinson's disease. This trial is currently on hold until we complete our cGMP processing center.
